Overview
Ulrich Terpitz practices practicing medicine in Wuerzburg, Germany.
His clinical expertise encompasses Acute Monoblastic Leukemia (AmoL) and Aspergillosis.
He is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ulrich Terpitz
Is Ulrich Terpitz a top-rated expert for Acute Monoblastic Leukemia (AmoL)?
MediFind is an objective health platform that identifies experts based on real-world data. Ulrich Terpitz is classified as an Experienced expert for Acute Monoblastic Leukemia (AmoL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ulrich Terpitz participate in research or clinical trials?
Yes. Ulrich Terpitz has published 24 articles and abstracts on conditions like Acute Monoblastic Leukemia (AmoL). You can view a list of Ulrich Terpitz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Monoblastic Leukemia (AmoL)Mr. Terpitz isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- AspergillosisMr. Terpitz isExperienced. Learn about Aspergillosis.